Phenobarbital Dosing Schedule for Alcohol Withdrawal Seizures
For alcohol withdrawal seizures, phenobarbital should be administered at 100-200 mg orally or intramuscularly in divided doses, not exceeding 600 mg daily, with gradual tapering by 30 mg per day as withdrawal symptoms resolve. 1
Initial Dosing and Administration
Loading dose approach:
Maintenance dosing:
Tapering Schedule
- Once stabilized (no withdrawal symptoms), decrease total daily dose by 30 mg per day 1
- If withdrawal symptoms reappear during tapering, maintain current dose or slightly increase until symptoms resolve 1
- Continue gradual tapering as tolerated
Monitoring Parameters
Assess for withdrawal symptoms using the CIWA-Ar scale:
- Mild withdrawal: <8 points
- Moderate withdrawal: 8-14 points
- Severe withdrawal: ≥15 points 2
Monitor for:
- Anxiety, muscle twitching, tremors (early signs)
- Convulsions and delirium (major withdrawal symptoms)
- Excessive sedation
- Respiratory depression
Clinical Considerations
- Phenobarbital appears to be as safe and effective as benzodiazepine-based protocols for treating high-risk alcohol withdrawal, with potentially lower rates of delirium 2, 3
- Recent evidence suggests phenobarbital may be associated with fewer seizures after administration compared to benzodiazepines (0% vs 5.67%) 4
- A 2019 study found that phenobarbital was effective even in patients who failed to respond to benzodiazepine treatment 5
Important Cautions
- The lethal dose of barbiturates is significantly lower when combined with alcohol 1
- Withdrawal symptoms can be severe and potentially fatal if not properly managed 1
- Major withdrawal symptoms (convulsions and delirium) may occur within 16 hours and last up to 5 days after abrupt cessation 1
- Withdrawal intensity gradually declines over approximately 15 days 1
Alternative Approach
For patients who cannot tolerate oral medication, an alternative fixed-dose phenobarbital protocol may be considered, which has shown similar or better outcomes compared to as-needed benzodiazepines, particularly regarding lower rates of delirium (0% vs 8.6%) 3
Adjunctive Therapy
- Administer thiamine 100-300 mg/day to prevent Wernicke encephalopathy 2
- Ensure thiamine is given before any IV glucose to prevent precipitating acute thiamine deficiency 2
- Monitor and correct electrolyte abnormalities (magnesium, potassium, phosphate) 2
While benzodiazepines remain first-line therapy according to most guidelines, phenobarbital represents an effective alternative, particularly for patients with refractory symptoms or those who cannot tolerate benzodiazepines 2, 4, 3.